BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2287566)

  • 1. [Results of the treatment of peripheral arterial diseases with PGE1].
    Borkowski M; Kruk M; Królicki L; Wojtal E; Malmurowicz L; Górewicz R; Laszuk D
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):505-8. PubMed ID: 2287566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
    Laurora G; Cesarone MR; Belcaro G; Incandela L; De Sanctis MT; Fascetti E; D'Archivio C
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intra-arterial infusion therapy of patients with the ischemic syndrome in thrombo-obliterating diseases of the lower extremities in ambulatory conditions].
    Savel'ev IuS
    Vestn Khir Im I I Grek; 1990 Sep; 145(9):131-4. PubMed ID: 1962927
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of intra-arterial administration of PGE1 prostaglandin].
    Ciostek P; Kostewicz W; Górski G
    Wiad Lek; 1994 Oct; 47(19-20):750-2. PubMed ID: 7483622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prostaglandin E1 on blood flow in normal and ischemic canine hindlimbs.
    Pasch AR; Ricotta JJ; Burke AR; O'Mara RE; DeWeese JA; Wilson G
    Surgery; 1984 Jun; 95(6):724-9. PubMed ID: 6539509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of patients with occlusive arterial diseases of the legs with prostaglandin E1].
    Dibirov MD
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):137-8. PubMed ID: 3222855
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of vasoprostan in the treatment of obliterating atherosclerosis of the lower limbs].
    Sukharev II; Guch AA
    Klin Khir (1962); 1994; (7):22-4. PubMed ID: 7823491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin therapy of peripheral occlusive arterial disease.
    Linhart J
    Sb Lek; 1998; 99(4):355-62. PubMed ID: 10803275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An evaluation of the results of intra-arterial injections in treating chronic ischemia of the lower extremities].
    Prokhorov GG
    Vestn Khir Im I I Grek; 1991; 147(7-8):41-4. PubMed ID: 1668930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 13. ["Responders and non-responders" to PGE1 and alpha-cyclodextrin].
    De Sanctis MT; Incandela L; Iacobitti P
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):31-6. PubMed ID: 10658442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Administration of the generic prostaglandin E1 VAP 20® in patients with lower limb critical ischaemia: a prospective study].
    Pokrovskiĭ AV; Chupin AV; Parshin PIu; Mikhaĭlov IP; Lavrenov VN; Kharazov AF; Kutyrev OE
    Angiol Sosud Khir; 2013; 19(2):17-20, 22-4. PubMed ID: 23863787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM; Savel'ev IuS
    Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of prostaglandin E1 infusion on limb hemodynamics and vasodilatory response in patients with arteriosclerosis obliterans.
    Makita S; Nakamura M; Ohhira A; Itoh S; Hiramori K
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):441-8. PubMed ID: 9310272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined treatment of aged patients with obliterative atherosclerosis of legs grade IV by intraarterial infusions and CO2-laser].
    Galimzianov FV; Belova AD
    Khirurgiia (Mosk); 1998; (12):18-21. PubMed ID: 9916427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A trial of the use of Vasaprostan in patients with arteriosclerosis obliterans of the lower extremities].
    Lebedev LV; Dobrynin EV; Luk'ianov IuV; Ignat'ev EI; Afonin DN
    Vestn Khir Im I I Grek; 1993; 150(5-6):151-3. PubMed ID: 8091568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.